A detailed history of Kbc Group Nv transactions in Myriad Genetics Inc stock. As of the latest transaction made, Kbc Group Nv holds 2,511 shares of MYGN stock, worth $55,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,511
Previous 2,511 -0.0%
Holding current value
$55,141
Previous $54,000 12.96%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$13.91 - $21.32 $53,470 - $81,954
-3,844 Reduced 60.49%
2,511 $48,000
Q3 2023

Feb 15, 2024

SELL
$15.99 - $23.22 $61,465 - $89,257
-3,844 Reduced 60.49%
2,511 $40,000
Q2 2023

Feb 15, 2024

SELL
$17.56 - $23.76 $11,027 - $14,921
-628 Reduced 8.99%
6,355 $147,000
Q1 2023

Feb 14, 2024

SELL
$15.26 - $23.75 $9,583 - $14,915
-628 Reduced 8.99%
6,355 $148,000
Q1 2023

May 04, 2023

SELL
$15.26 - $23.75 $9,583 - $14,915
-628 Reduced 8.99%
6,355 $148,000
Q3 2022

Feb 15, 2024

BUY
$18.21 - $27.88 $81,435 - $124,679
4,472 Added 178.1%
6,983 $133,000
Q2 2022

Feb 14, 2024

BUY
$16.45 - $25.88 $95,903 - $150,880
5,830 Added 505.64%
6,983 $127,000
Q2 2022

Jul 26, 2022

BUY
$16.45 - $25.88 $114,870 - $180,720
6,983 New
6,983 $127,000
Q1 2022

May 06, 2022

SELL
$22.67 - $28.01 $26,138 - $32,295
-1,153 Closed
0 $0
Q4 2021

Feb 14, 2024

SELL
$24.13 - $32.63 $32,768 - $44,311
-1,358 Reduced 54.08%
1,153 $32,000
Q3 2021

Nov 10, 2021

SELL
$29.97 - $36.66 $436,033 - $533,366
-14,549 Reduced 92.66%
1,153 $37,000
Q2 2021

Aug 11, 2021

BUY
$25.39 - $32.61 $77,337 - $99,330
3,046 Added 24.07%
15,702 $480,000
Q4 2020

Feb 10, 2021

SELL
$12.16 - $19.77 $24,271 - $39,460
-1,996 Reduced 13.62%
12,656 $250,000
Q3 2020

Oct 28, 2020

SELL
$11.25 - $14.75 $46,091 - $60,430
-4,097 Reduced 21.85%
14,652 $191,000
Q2 2020

Aug 10, 2020

SELL
$10.69 - $16.49 $264,417 - $407,880
-24,735 Reduced 56.88%
18,749 $213,000
Q1 2020

May 04, 2020

BUY
$9.78 - $29.53 $110,709 - $334,279
11,320 Added 35.19%
43,484 $622,000
Q1 2019

May 10, 2019

BUY
$26.93 - $34.7 $463,438 - $597,152
17,209 Added 115.07%
32,164 $0
Q4 2018

Jan 31, 2019

SELL
$27.23 - $45.56 $756,013 - $1.26 Million
-27,764 Reduced 64.99%
14,955 $434,000
Q3 2018

Nov 14, 2018

BUY
$37.57 - $50.34 $1.18 Million - $1.59 Million
31,532 Added 281.86%
42,719 $0
Q2 2018

Aug 03, 2018

SELL
$27.75 - $40.17 $99,428 - $143,929
-3,583 Reduced 24.26%
11,187 $0
Q1 2018

May 09, 2018

BUY
$28.83 - $41.01 $218,444 - $310,732
7,577 Added 105.34%
14,770 $0
Q4 2017

Feb 07, 2018

BUY
$28.45 - $37.14 $55,818 - $72,868
1,962 Added 37.51%
7,193 $0
Q3 2017

Nov 13, 2017

BUY
$24.01 - $36.2 $125,596 - $189,362
5,231
5,231 $0

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.